Search for: "COBALT PHARMACEUTICALS" Results 41 - 60 of 70
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Mar 2009, 8:00 am
(Intellectual Property Watch) Two final thoughts on big pharma acquisitions (IP finance) Brazil: Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Brazil: Patent term cutbacks - Lobbying, intellectual property and superior courts (IP Think Tank) Brazil: Patent term extension (PTE) under TRIPs revisited and reviewed by Superior Court of Justice (IP tango) Denmark: Harmonisation in Denmark: Patents covering… [read post]
16 Nov 2007, 4:00 am
: (LawFont),BrazilBrazil pays the price for compulsory licensing: (IAM), (Generic Pharmaceuticals & IP), CanadaThe Chronicle reports that Honourable Mr. [read post]
18 Feb 2020, 1:04 pm by Kevin LaCroix
  The two cases that made the Top 100 list during 2019 are Cobalt International Energy, at $389.6 million, the 43rd largest of all time; and Alibaba Group Holding, at $250 million, tied for 69th largest. [read post]
11 Mar 2020, 1:19 pm by Kevin LaCroix
Of this total, $389.6 was obtained in the largest of the 2019 settlements, involving Cobalt International Energy. [read post]
28 Jun 2012, 10:44 pm
DePuy Orthopedics is the division of Johnson & Johnson, the American pharmaceutical and cosmetic conglomerate, responsible for manufacturing the defective implants. [read post]
19 Feb 2015, 5:05 pm by Dr. Shezad Malik
DePuy a subsidiary of the pharmaceutical giant, Johnson and Johnson, issued a worldwide recall in 2010 after they acknowledged the high risk of premature failure of the metal on metal hip implant. [read post]
31 Aug 2012, 8:20 am by Cal Warriner
According to the journal Orthopedics, metal-on-metal hip replacement joints have been found to “exhibit increased serum cobalt and chromium ion levels. [read post]
8 May 2009, 8:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) – US: Federal Circuit revises Amgen v ITC (Patently-O) (Patent Baristas) (ITC 337 Law Blog) (Hal Wegner) (Patent Docs)   General Alicia Greenidge to step down as Director of IFPMA (Intellectual Property Watch) Flu crisis could lead to compulsory licences (Managing… [read post]
5 Jan 2008, 6:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]GlobalComing out of copyright - some notable deaths from 1937: (IPKat),Design patents: No longer the province of individual inventors: (Patently O),Fail fast, ready fire aim and Stanford v Cal: (IP Think Tank),Walls, Alexander the Great and Partha Bose: (IP Think Tank),A fair use primer for online content creators: (Ars Technica)ISO moves to create global… [read post]
14 Dec 2007, 1:00 am
: (Patent Prospector)  PharmaAggregate launches new online presence: (MaRS Blog - Innovation and Commercialization in Canada)Japan Plans Generic Drug Incentives to Cut Down Medical Costs: (MedIndia), Interesting commentary and article on generic/ innovator company patent settlements: (Generic Pharmaceuticals & IP), Global trends in commencement of patent actions by innovators: (Generic Pharmaceuticals & IP), Is… [read post]
9 Apr 2009, 7:52 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent Infringement Updates) (Patently-O) (Patent Docs) Xigris (Drotrecogin alfa) –US: CAFC: Pioneering claims require more expansive written description: Ariad v Eli… [read post]
29 Apr 2014, 1:39 pm by Barry Barnett
The Supreme Court today granted certiorari in Teva Pharmaceuticals USA, Inc. v. [read post]
23 Jan 2017, 9:48 am by Altman & Altman
If cobalt, titanium, or chromium ions are released into the bloodstream, toxicity, inflammation, and even cancer can result. [read post]
24 Nov 2011, 4:46 pm
Furthermore, DePuy, a subsidiary of Johnson and Johnson, one of the world's largest medical device and pharmaceutical company, has been eerily quiet. [read post]
17 Mar 2021, 2:06 pm by Kevin LaCroix
By contrast the largest settlement in 2019 was the $389.6 billion settlement in the Cobalt International Energy securities suit. [read post]
27 Oct 2010, 3:38 am by Kelly
Abbott (EPLAW) Lunesta (Eszopiclone) – US: Cobalt Pharmaceuticals and Sepracor settle Lunesta patent litigation (Patent Docs) Mirapex (Pramipexole) – US: Mylan receives approval for generic version of Mirapex tablets (SmartBrief) Oracea (Doxycyline) – US: Mylan seeks declaratory judgment of non-infringement and invalidity based on ANDA filing: Mylan v Galderma (Patent Docs) Perlane, Restylane (Hyaluronic acid) – US: Genzyme files patent infringement… [read post]
27 Apr 2022, 12:16 am by MaxVal
The stent is formed of a radiopaque cobalt-chromium-nickel-tungsten (Co–Cr–Ni–W) alloy with specifically elevated tungsten content to ensure that the alloy maintains a single-phase, face-centered-cubic (FCC) microstructure for higher radiopacity. [read post]